D000914Chemicals & DrugsD12.776.124.486.485.114.254D12.776.124.790.651.114.254D12.776.377.715.548.114.25426540.965232Antibodies, Viralprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryMicrobiology and ImmunologyWake Forest School of MedicineChristopherPoradaChristopher Porada PhD36.08943500000000-80.26863200000000164Porada, ChristopherProfessorDouglasLylesDouglas S. Lyles PhD36.08919100000000-80.26677800000000233Lyles, DouglasProfessorJasonGraysonJason M. Grayson PhD36.08977400000000-80.26684000000000419Grayson, JasonAssociate ProfessorKatherinePoehlingKatherine A. Poehling MD, MPH36.08915800000000-80.26686200000000545Poehling, KatherineProfessorMarthaAlexander-Miller4MC38pybvDqOTrPFxxARchSSnXEUZ/41PeKUY3jDi/Sa+yrfEF0=Martha A. Alexander-Miller PhD36.09032400000000-80.26649100000000603Alexander-Miller, MarthaProfessor33237893Self WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, Ginde AA, Prekker ME, Brown SM, Peltan ID, Gong MN, Aboodi MS, Khan A, Exline MC, Files DC, Gibbs KW, Lindsell CJ, Rice TW, Jones ID, Halasa N, Talbot HK, Grijalva CG, Casey JD, Hager DN, Qadir N, Henning DJ, Coughlin MM, Schiffer J, Semenova V, Li H, Thornburg NJ, Patel MMMMWR. Morbidity and mortality weekly reportSelf WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, Ginde AA, Prekker ME, Brown SM, Peltan ID, Gong MN, Aboodi MS, Khan A, Exline MC, Files DC, Gibbs KW, Lindsell CJ, Rice TW, Jones ID, Halasa N, Talbot HK, Grijalva CG, Casey JD, Hager DN, Qadir N, Henning DJ, Coughlin MM, Schiffer J, Semenova V, Li H, Thornburg NJ, Patel MM. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 27; 69(47):1762-1766.MMWR Morb Mortal Wkly Rep2020-11-27T00:00:002020Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.32881855Self WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, Ginde AA, Prekker ME, Brown SM, Peltan ID, Gong MN, Aboodi MS, Khan A, Exline MC, Files DC, Gibbs KW, Lindsell CJ, Rice TW, Jones ID, Halasa N, Talbot HK, Grijalva CG, Casey JD, Hager DN, Qadir N, Henning DJ, Coughlin MM, Schiffer J, Semenova V, Li H, Thornburg NJ, Patel MMMMWR. Morbidity and mortality weekly reportSelf WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, Ginde AA, Prekker ME, Brown SM, Peltan ID, Gong MN, Aboodi MS, Khan A, Exline MC, Files DC, Gibbs KW, Lindsell CJ, Rice TW, Jones ID, Halasa N, Talbot HK, Grijalva CG, Casey JD, Hager DN, Qadir N, Henning DJ, Coughlin MM, Schiffer J, Semenova V, Li H, Thornburg NJ, Patel MM. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 04; 69(35):1221-1226.MMWR Morb Mortal Wkly Rep2020-09-04T00:00:002020Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.Pediatrics, GeneralWake Forest Institute for Regenerative Medicine31582360Beigel JH, Aga E, Elie-Turenne MC, Cho J, Tebas P, Clark CL, Metcalf JP, Ozment C, Raviprakash K, Beeler J, Holley HP, Warner S, Chorley C, Lane HC, Hughes MD, Davey RTThe Lancet. Respiratory medicineBeigel JH, Aga E, Elie-Turenne MC, Cho J, Tebas P, Clark CL, Metcalf JP, Ozment C, Raviprakash K, Beeler J, Holley HP, Warner S, Chorley C, Lane HC, Hughes MD, Davey RT. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. Lancet Respir Med. 2019 11; 7(11):941-950.Lancet Respir Med2019-09-30T00:00:002019Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.33208941Wieland A, Patel MR, Cardenas MA, Eberhardt CS, Hudson WH, Obeng RC, Griffith CC, Wang X, Chen ZG, Kissick HT, Saba NF, Ahmed RNatureWieland A, Patel MR, Cardenas MA, Eberhardt CS, Hudson WH, Obeng RC, Griffith CC, Wang X, Chen ZG, Kissick HT, Saba NF, Ahmed R. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature. 2021 Sep; 597(7875):274-278.Nature2020-11-18T00:00:002020Defining HPV-specific B cell responses in patients with head and neck cancer.33020185Theel ES, Couturier MR, Filkins L, Palavecino E, Mitchell S, Campbell S, Pentella M, Butler-Wu S, Jerke K, Dharmarha V, McNult P, Schuetz ANJournal of clinical microbiologyTheel ES, Couturier MR, Filkins L, Palavecino E, Mitchell S, Campbell S, Pentella M, Butler-Wu S, Jerke K, Dharmarha V, McNult P, Schuetz AN. Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization. J Clin Microbiol. 2020 12 17; 59(1).J Clin Microbiol2020-12-17T00:00:002020Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor1.780650.010484326research area of0.8010390.01086250subject area for